Peripheral Interventions Market Size By Product (Catheters, Sheath, Stents {Bare-metal Stents, Drug-eluting Stents}, Guide Wires, Atherectomy Devices, Embolic Devices, Thrombectomy Devices, IVC Filters), By Application (Peripheral Artery Disease, Venous Thromboembolism), By End-use (Hospitals, Catheterization Laboratories, Ambulatory Surgical Centres), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

Published Date: Mar 2021  |  Report ID: GMI2915  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 250   |   Base Year: 2020

Summary Table of Contents Industry Coverage Methodology

Industry trends

Peripheral Interventions Market size was valued at USD 6.8 billion in 2020 and is expected to witness an 8% CAGR from 2021 to 2027. Growing geriatric pool worldwide coupled with rising incidence of chronic cardiovascular disorders will be major driving factors for the market growth.

Peripheral Interventions Market Research Report

Get more details on this report - Request Free Sample PDF

Peripheral interventions are a minimally invasive procedure used to treat peripheral artery disorders (PAD). Various products such as atherectomy devices, balloon catheters and stent systems are used for treating the plaque that is built up in patients suffering from several vascular disorders including atherosclerosis, critical limb ischemia and fibroids among others.

Growing technological advancements in peripheral interventions devices will offer lucrative market expansion opportunities. Technological advances including emergence of drug-eluting stents, drug-coated balloons, use of nanotechnology and several other breakthroughs have increased the procedure outcome and success rate. For instance, advances in drug-eluting stent (DES) technology have improved the management of peripheral artery disease. The drug-eluting stents inhibit restenosis through controlled release of an antiproliferative agent, e.g. Paclitaxel, improving long-term patency rates. Furthermore, benefits such as flexibility, strength, deliverability and visibility of these devices will further boost the adoption of advanced products for peripheral interventional procedures, thus leading to the high market value in the future.

Rising expenditure in research and development will drive the peripheral interventions market revenue

Growing prevalence of cardiovascular disorders (CVD) has created high demand for peripheral interventions procedure. Major risk factors of development of some form of CVD include hypertension, diabetes, obesity, smoking and acceptance of a sedentary lifestyle. Additionally, increasing geriatric population across the world is significantly contributing to disease prevalence. Collective pervasiveness of these risk factors leading to cardiovascular disease has significantly increased healthcare expenditure for research and development by the government and major market players. Companies such as Boston Scientific Corporation, and Abbott Laboratories, among others, are providing advanced vascular devices to healthcare professionals, further enabling high-quality procedures and outcomes. Thus, innovations will influence the sales of peripheral intervention devices during the forecast period.

The COVID-19 pandemic negatively impacted the peripheral intervention procedures in the initial phase of 2020. Decline in non-urgent procedures globally reduced the industry value up to some extent. For instance, the European Society of Cardiology recommended deferring all non-emergency procedures including peripheral vascular interventions during onset of pandemic. This led to a reduction in the number of patients presenting to the emergency department (ED) with peripheral artery disease. However, relaxation in restrictions and reduced number of COVID-19 cases in subsequent phase of 2020 recovered the market demand eventually.

Increasing adoption of minimally invasive procedures and launch of innovative products will augment the segment demand

Peripheral Interventions Market Size, By Product

Get more details on this report - Request Free Sample PDF

The catheters segment in the peripheral interventions market is projected to expand at an 8.2% growth rate till 2027 on account of easy diagnosis, technological advancements and better outcomes through the use of catheters.

Catheter is an essential component of peripheral interventional procedure, used to diagnose and treat blockages in blood vessels during the treatment. Technological advancements in catheters have further enabled healthcare professionals to visualize and operate lesions in vessel and delivering appropriate disease treatment, thereby impelling the segment growth in the coming years.

Rising geriatric population and growing incidence of vascular disorders will increase the demand for peripheral intervention procedures

The peripheral artery disease segment held 50% of the market share in 2020. Increasing prevalence of peripheral artery diseases will accelerate the usage of various peripheral vascular devices.

With rising geriatric population, the risk and incidence of PAD is increasing substantially. Other risk factors associated with the disease such as high cholesterol, diabetes, excess weight, smoking among several others are contributing to the patient pool. Thus, with growing PAD pervasiveness coupled with an increasing awareness rate, the market will experience expansion.

Skilled workforce and sophisticated infrastructure will spur the demand for peripheral vascular devices in hospitals

Hospitals end-use segment in the peripheral interventions market dominated more than 82% of revenue share in 2020. Factors such as hospital infrastructure and benefits of surgical procedure outcome with usage of advanced technology will increase the segment revenue.

Presence of a skilled workforce and the availability of catheterization laboratories within the hospital premises will foster the segment value. Furthermore, advantages such as large-scale operations, multi-functionality, capacity to invest in advanced devices for peripheral interventions, will further fuel the hospital segment size.

Growing healthcare expenditure and presence of major market players will positively impact the North America market size

North America peripheral interventions market accounted for 38% of revenue share in 2020 owing to presence of major companies in the region and skilled workforce in the healthcare settings. Major players such as Boston Scientific Corporation, Medtronic, Johnson & Johnson and Becton Dickinson have a strong foothold in North America, especially in the U.S. In addition, healthcare professionals rapidly adopt breakthrough products in the region, thereby creating attractive opportunities for the industry participants.

Large population suffering from various CVDs puts cost burden. Americans spend over USD 200 billion on CVDs each year. With growing costs, the need for effective treatment is also increasing, thereby offering innovation potential to the firms. Additionally, growing awareness about early diagnosis and treatment of PAD in Canada will further drive the demand for interventional devices in the region.

New product development and geographical expansion are key strategies adopted by major market leaders

Major companies involved in the peripheral interventions market include Abbott, Becton Dickinson & Company, Boston Scientific Corporation, Cook Group and Medtronic among other market players. These industry participants have incorporated certain strategic initiatives such as new product development and launch, collaborations, acquisitions and others that have enhanced their business hold and helped them evolve as major market leaders.

Some of the recent industry developments:

  • In April 2019, BD announced launch of UltraScore 014. to introduce a simplified method for treatment of obstructive lesions of kidney arteria and femoral. This product launch will increase customer base, generating more revenue for an organization.
  • In October 2019, AngioDynamics acquired an early stage medical company named Eximo Medical, Ltd., resulting into acquisition of their 355nm wavelength laser-technology platform. This strategic acquisition will expand firm’s existing business.

Peripheral Interventions Market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027 for the following segments:

Market, By Product                   

  • Catheters
  • Sheath
  • Stents
    • Bare-metal Stents
    • Drug-eluting Stents
    • Others
  • Guide Wires
  • Atherectomy Devices
  • Embolic Devices
  • Thrombectomy Devices
  • IVC Filters
  • Others

Market, By Application

  • Peripheral Artery Disease
  • Venous Thromboembolism
  • Others

Market, By End-use

  • Hospitals
  • Catheterization Laboratories
  • Ambulatory Surgical Centres
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Russia
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • UAE

Frequently Asked Questions (FAQ) :

Peripheral interventions market accounted for a revenue share of USD 6.8 billion in 2020 and will grow at a CAGR of 8% through 2027.
Peripheral interventions market from catheters will grow at an 8.2% rate through 2027 owing to technological innovations, easy diagnosis and better outcomes.
Peripheral artery disease segment captured 50% of the overall revenue share in 2020 and will grow as rising incidences of such health issues increase the demand for various peripheral vascular devices.
Hospitals accounted for 82% of the market share and will expand owing to the benefits like state-of-the-art infrastructure and usage of advanced technology.
North America held 38% of peripheral interventions market share in 2020 and will record notable growth numbers due to the presence of a skilled workforce in the healthcare settings and key market players.

Premium Report Details

  • Published Date: Mar 2021
  • Pages: 250
  • Tables: 245
  • Charts / Figures: 13
  • Companies covered: 14
  • Countries covered: 18

Get a report that explains COVID-19 impact on this market

Buy Now

Need a Discount? Get in touch with us for special pricing

Request Discount

 Connect with our sales team

Chat with us
We use cookies to enhance user experience. (Privacy Policy) X